BioTek’s new Synergy H4 Hybrid Microplate Reader has received Transcreener approval from BellBrook Labs. The approval extends to the Transcreener Fluorescence Polarization, Far Red, Red Fluorescence (FI) and Red TR-FRET assays, and means that the Synergy H4 meets strict standards in instrument setup and assay performance.
Synergy H4 is a new class of multi-mode microplate readers that uses patent pending Hybrid Technology to combine sensitive filter-based optics and flexible monochromator-based optics in one compact instrument for endless flexibility in current and future microplate-based assay choice. Additionally, Synergy H4 is compatible with BioTek’s Take3 Multi-Volume Plate for low-volume measurements down to 2 µL.
BioTek
Filed Under: Drug Discovery
